Log in to save to my catalogue

Intravenous enoxaparin or unfractionated heparin in primary percutaneous coronary intervention for S...

Intravenous enoxaparin or unfractionated heparin in primary percutaneous coronary intervention for S...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_893267902

Intravenous enoxaparin or unfractionated heparin in primary percutaneous coronary intervention for ST-elevation myocardial infarction: the international randomised open-label ATOLL trial

About this item

Full title

Intravenous enoxaparin or unfractionated heparin in primary percutaneous coronary intervention for ST-elevation myocardial infarction: the international randomised open-label ATOLL trial

Publisher

Kidlington: Elsevier Ltd

Journal title

The Lancet (British edition), 2011-08, Vol.378 (9792), p.693-703

Language

English

Formats

Publication information

Publisher

Kidlington: Elsevier Ltd

More information

Scope and Contents

Contents

Summary Background Primary percutaneous coronary intervention (PCI) for ST-elevation myocardial infarction has traditionally been supported by unfractionated heparin, which has never been directly compared with a new anticoagulant using consistent anticoagulation and similar antiplatelet strategies in both groups. We compared traditional heparin tr...

Alternative Titles

Full title

Intravenous enoxaparin or unfractionated heparin in primary percutaneous coronary intervention for ST-elevation myocardial infarction: the international randomised open-label ATOLL trial

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_miscellaneous_893267902

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_893267902

Other Identifiers

ISSN

0140-6736

E-ISSN

1474-547X

DOI

10.1016/S0140-6736(11)60876-3

How to access this item